A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial

BACKGROUND: Some cancers such as sarcomas (bone and soft tissue sarcomas) and adenoid cystic carcinomas are considered as radioresistant to low linear energy transfer radiation (including photons and protons) and may therefore beneficiate from a carbon ion therapy. Despite encouraging results obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Balosso, Jacques, Febvey-Combes, Olivia, Iung, Annie, Lozano, Hélène, Alloh, Abdoulkader Soumai, Cornu, Catherine, Hervé, Magali, Akkal, Zohra, Lièvre, Michel, Plattner, Valérie, Valvo, Francesca, Bono, Cristina, Fiore, Maria Rosaria, Vitolo, Viviana, Vischioni, Barbara, Patin, Stéphanie, Allemand, Hubert, Gueyffier, François, Margier, Jennifer, Guerre, Pascale, Chabaud, Sylvie, Orecchia, Roberto, Pommier, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128242/
https://www.ncbi.nlm.nih.gov/pubmed/35606739
http://dx.doi.org/10.1186/s12885-022-09564-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128242/
https://www.ncbi.nlm.nih.gov/pubmed/35606739
http://dx.doi.org/10.1186/s12885-022-09564-7

Ejemplares similares